Compare XBIO & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XBIO | KXIN |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9M | 4.7M |
| IPO Year | N/A | N/A |
| Metric | XBIO | KXIN |
|---|---|---|
| Price | $2.41 | $3.50 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 47.5K | ★ 1.5M |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,858,935.00 | $95,000.00 |
| Revenue This Year | $1.99 | N/A |
| Revenue Next Year | $20.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.30 | N/A |
| 52 Week Low | $2.20 | $2.94 |
| 52 Week High | $13.93 | $75.00 |
| Indicator | XBIO | KXIN |
|---|---|---|
| Relative Strength Index (RSI) | 40.78 | 56.94 |
| Support Level | $2.31 | $3.74 |
| Resistance Level | $2.64 | $5.40 |
| Average True Range (ATR) | 0.18 | 0.69 |
| MACD | 0.05 | 0.16 |
| Stochastic Oscillator | 31.65 | 55.80 |
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.